NERM
IMPV

New England Research & Management’s Imperva, Inc. IMPV Stock Holding History

New England Research & Management’s Portfolio IMPV Stock Details IMPV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-4,000
Closed -$202K – 178
2016
Q1 		$202K Buy
+4,000
New +$192K 0.17% 151

Other funds holding IMPV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
EM
Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
PCM
Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

New England Research & Management's IMPV Position: Q2 2016 in Review

New England Research & Management sold out of Imperva, Inc. (IMPV) in Q2 2016, closing a stake of 4,000 shares — an estimated $202K sold.

New England Research & Management first reported a position in IMPV in Q1 2016 and held it in 1 quarter. The position peaked at $202K in Q1 2016. 176 funds tracked by Wall St. Rank hold IMPV as of Q2 2016.

  • New England Research & Management reported no remaining Imperva, Inc. position as of Q2 2016 after selling out during the quarter.
  • New England Research & Management sold 4,000 Imperva, Inc. shares in Q2 2016, an estimated $202K.
  • New England Research & Management first reported a position in Imperva, Inc. in Q1 2016 and held it in 1 quarter.
  • New England Research & Management's Imperva, Inc. position peaked at $202K in Q1 2016.
  • 176 funds tracked by Wall St. Rank held Imperva, Inc. as of Q2 2016.

Based on New England Research & Management's 13F filing for Q2 2016, filed 5 Jul 2016.